We hypothesized that a more refined understanding of MC4R signaling and its impact on clinical phenotypes in the general population may inform the design of drugs targeting this pathway to treat common obesity and its complications. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.